Examining the effect of Tranexamic Acid (TXA) on the functional fibrinolysis assay in patients with hereditary bleeding disorder (HBD) compared with healthy controls.
Not Applicable
Not yet recruiting
- Conditions
- Hereditary Bleeding Disorder (Haemophilia A and B, Von Willebrand disease)Blood - Clotting disordersHuman Genetics and Inherited Disorders - Other human genetics and inherited disorders
- Registration Number
- ACTRN12615000311550
- Lead Sponsor
- Alfred Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
One of Hereditary Bleeding Disorder = Haemophilia A, Haemophilia B, or rarer coagulation factor deficiencies {such as factor XI deficiency} and von Willebrand Disease)
Exclusion Criteria
Pregnant or breastfeeding
Past history of thrombosis
Past history of renal disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method